Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Orchid Chemicals & Pharmaceuticals discloses new HDAC6 inhibitors

Sep. 25, 2012

Novel LRRK2 inhibitors prepared at Merck & Co.

Sep. 25, 2012

New amatoxin conjugates patented by Heidelberg Pharma

Sep. 25, 2012

Cancer Therapeutics CRC synthesizes novel FADK inhibitors

Sep. 21, 2012

New efflux pump inhibitors for bacterial infections disclosed

Sep. 21, 2012

Novel cannabinoid CB1 receptor allosteric modulators discovered at University of Aberdeen

Sep. 21, 2012

Treventis prepares new anti-amyloid compounds

Sep. 21, 2012

Janssen Pharmaceutica presents new BACE1 inhibitors

Sep. 21, 2012

Korean researchers patent novel antiviral compositions

Sep. 21, 2012

Belgian and U.S. researchers synthesize novel agents for viral infections

Sep. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...